NL-OMON49211已完成不适用
A phase 1, double-blind placebo-controlled single and multiple ascending dose study of the safety, tolerability, pharmacokinetics, pharmacodynamics and food effects of IFM-2427 in healthy subjects - IFM 2427 SAD MAD FE study to investigate safety, PK and PD
IFM Therapeutics0 个研究点目标入组 136 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 136
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Gender : male or female; females must be of non-childbearing potential
- •- Age : 18 to 64 years, inclusive, at screening.
- •- Body mass index (BMI) : 18.5 to 30.0 kg/m2 at screening.
- •- Weight : >=50 kg at screening.
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of
- •participation in another drug study within 90 days before the start of this
- •study or being a blood donor within 60 days from the start of the study. In
- •case of donating more than 1.5 liters of blood in the 10 months prior the start
- •of this study.
研究者
相似试验
已完成
不适用
A Phase 1 Double-Blind, Placebo-Controlled, Single- and Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Nipocalimab in Healthy Male and Female Participants.NL-OMON50999Janssen-Cilag60
已完成
不适用
A Phase 1 Double-blind, Placebo-controlled, Single- and Multiple-ascending-dose Study of KHK6640 in Alzheimer's DiseaseAlzheimer's diseaseDementiaNL-OMON44211Kyowa Hakko15
已完成
1 期
Safety and tolerability of single and multiple-ascending doses of the study drug ACP-014 in Healthy volunteers.HypoparathyroidismACTRN12617001375347Ascendis Pharma Bone Diseases A/S186
进行中（未招募）
1 期
Study of effects of AUT00206 in healthy males - ketamine challengeSchizophreniaEUCTR2016-000216-14-GBAutifony Therapeutics Limited
进行中（未招募）
不适用
A Phase 1-2, Randomized, Placebo-Controlled, Single-Blind, Dose Escalation Study to Evaluate the Safety, Tolerability, and Activity of Ascending Single Doses of MRX-801 with Continuous Ultrasound Administration in Subjects with Acute Ischemic Stroke Receiving Treatment with Intravenous Tissue Plasminogen ActivatorAcute Ischemic StrokeMedDRA version: 8.1Level: LLTClassification code 10055221Term: Ischemic strokeEUCTR2006-005491-40-DEImaRx Therapeutics, Inc72